Annual EBIT:
-$108.11M+$24.56M(+18.51%)Summary
- As of today, TARS annual earnings before interest & taxes is -$108.11 million, with the most recent change of +$24.56 million (+18.51%) on December 31, 2024.
- During the last 3 years, TARS annual EBIT has fallen by -$94.33 million (-684.98%).
- TARS annual EBIT is now -7907.93% below its all-time high of -$1.35 million, reached on December 31, 2018.
Performance
TARS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$14.53M+$7.66M(+34.51%)Summary
- As of today, TARS quarterly earnings before interest & taxes is -$14.53 million, with the most recent change of +$7.66 million (+34.51%) on September 30, 2025.
- Over the past year, TARS quarterly EBIT has increased by +$10.63 million (+42.26%).
- TARS quarterly EBIT is now -235.61% below its all-time high of $10.71 million, reached on March 31, 2021.
Performance
TARS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$87.41M+$10.63M(+10.84%)Summary
- As of today, TARS TTM earnings before interest & taxes is -$87.41 million, with the most recent change of +$10.63 million (+10.84%) on September 30, 2025.
- Over the past year, TARS TTM EBIT has increased by +$53.18 million (+37.83%).
- TARS TTM EBIT is now -13709.48% below its all-time high of -$633.00 thousand, reached on September 30, 2019.
Performance
TARS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TARS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +18.5% | +42.3% | +37.8% |
| 3Y3 Years | -685.0% | +36.6% | -40.7% |
| 5Y5 Years | -2415.3% | -43.3% | -613.1% |
TARS EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -685.0% | +18.5% | at high | +67.3% | -40.7% | +44.1% |
| 5Y | 5-Year | -2415.3% | +18.5% | -235.6% | +67.3% | -2323.4% | +44.1% |
| All-Time | All-Time | -7907.9% | +18.5% | -235.6% | +67.3% | >-9999.0% | +44.1% |
TARS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$14.53M(+34.5%) | -$87.41M(+10.8%) |
| Jun 2025 | - | -$22.18M(+15.6%) | -$98.05M(+10.2%) |
| Mar 2025 | - | -$26.28M(-7.6%) | -$109.17M(+9.5%) |
| Dec 2024 | -$108.11M(+18.5%) | -$24.42M(+2.9%) | -$120.57M(+14.2%) |
| Sep 2024 | - | -$25.16M(+24.4%) | -$140.60M(+10.1%) |
| Jun 2024 | - | -$33.30M(+11.6%) | -$156.37M(-0.3%) |
| Mar 2024 | - | -$37.68M(+15.2%) | -$155.89M(-8.9%) |
| Dec 2023 | -$132.67M(-121.0%) | -$44.45M(-8.6%) | -$143.16M(-25.8%) |
| Sep 2023 | - | -$40.94M(-24.7%) | -$113.77M(-18.8%) |
| Jun 2023 | - | -$32.82M(-31.5%) | -$95.74M(-40.5%) |
| Mar 2023 | - | -$24.95M(-65.7%) | -$68.14M(-8.7%) |
| Dec 2022 | -$60.03M | -$15.06M(+34.2%) | -$62.71M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$22.91M(-338.5%) | -$62.12M(-13.1%) |
| Jun 2022 | - | -$5.22M(+73.2%) | -$54.92M(-29.5%) |
| Mar 2022 | - | -$19.52M(-34.9%) | -$42.42M(-248.2%) |
| Dec 2021 | -$13.77M(+49.0%) | -$14.47M(+7.9%) | -$12.18M(-32.8%) |
| Sep 2021 | - | -$15.71M(-315.7%) | -$9.17M(-154.3%) |
| Jun 2021 | - | $7.28M(-32.0%) | -$3.61M(+66.9%) |
| Mar 2021 | - | $10.71M(+193.5%) | -$10.89M(+54.1%) |
| Dec 2020 | -$27.00M(-528.2%) | -$11.46M(-13.0%) | -$23.72M(-93.5%) |
| Sep 2020 | - | -$10.14M(-378.8%) | -$12.26M(-345.6%) |
| Mar 2020 | - | -$2.12M(-234.6%) | -$2.75M(-334.6%) |
| Dec 2019 | -$4.30M(-218.4%) | - | - |
| Sep 2019 | - | -$633.00K | -$633.00K |
| Dec 2018 | -$1.35M | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of TARS is -$108.11M
What is the all-time high annual EBIT for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$1.35M
What is Tarsus Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, TARS annual earnings before interest & taxes has changed by +$24.56M (+18.51%)
What is Tarsus Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of TARS is -$14.53M
What is the all-time high quarterly EBIT for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $10.71M
What is Tarsus Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, TARS quarterly earnings before interest & taxes has changed by +$10.63M (+42.26%)
What is Tarsus Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of TARS is -$87.41M
What is the all-time high TTM EBIT for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$633.00K
What is Tarsus Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, TARS TTM earnings before interest & taxes has changed by +$53.18M (+37.83%)